FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284881750> ?p ?o ?g. }

• W4284881750 endingPage "595" @default.
• W4284881750 startingPage "587" @default.
• W4284881750 abstract "Elderly people who reside in long-term care facilities form a frail and vulnerable population, with multiple pathologies and high percentages of cognitive and functional disability. The aims of this study were to assess the safety of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in frail nursing home residents and to evaluate its effectiveness 6 months after full vaccination. This was an ambispective observational study. Residents of a long-term care facility in Madrid, Spain. One hundred and thirty-seven nursing home residents (81.8% female, mean age 87.77 ± 8.31 years) with high comorbidity (61.3% Charlson Index ≥ 3) and frailty (75% Clinical Frail Scale ≥ 7) who received the BNT162B2 mRNA vaccine. Safety data were collected to evaluate the type of adverse drug reactions and their duration, severity, and causality. Immunogenicity was tested 6 months after the primary vaccination and effectiveness was evaluated by the incidence of SARS-CoV-2 infection, the number of hospital admissions, and mortality due to coronavirus disease 2019 (COVID-19). Safety: Of the residents, 21.9% had some adverse reaction and 5.8% had a severe or more serious adverse reaction. The most frequent adverse reactions were fatigue (13.1%), pyrexia (12.4%), and headache (7.3%). No association was observed between frailty (including a need for palliative care) and clinical, functional or cognitive status of the participants and the occurrence of adverse events. Immunogenicity and Effectiveness: After 6 months of vaccination, only one case of SARS-CoV-2 infection was confirmed in the vaccinated residents. Most of the nursing home residents presented positive serology (95.2%). Loss of immunogenicity was associated with older age (95.12 ± 3.97 vs. 87.24 ± 8.25 years; p = 0.03) and no previous COVID-19 infection (16.6% vs. 70%; p < 0.001). Binary logistic regression models did not reveal this association. The BNT162B2 vaccine is well tolerated and effective in nursing home residents, independently of their clinical, functional, cognitive, or frailty characteristics. For the most part, immunogenicity has been maintained over time, regardless of comorbidity, functional status or frailty." @default.
• W4284881750 created "2022-07-09" @default.
• W4284881750 creator A5003834978 @default.
• W4284881750 creator A5031844966 @default.
• W4284881750 creator A5032654392 @default.
• W4284881750 creator A5033721701 @default.
• W4284881750 creator A5056707805 @default.
• W4284881750 creator A5057345227 @default.
• W4284881750 creator A5058418590 @default.
• W4284881750 creator A5058618178 @default.
• W4284881750 creator A5061049836 @default.
• W4284881750 creator A5065593598 @default.
• W4284881750 creator A5081399033 @default.
• W4284881750 date "2022-07-01" @default.
• W4284881750 modified "2023-10-09" @default.
• W4284881750 title "Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents" @default.
• W4284881750 cites W2505087320 @default.
• W4284881750 cites W2583058854 @default.
• W4284881750 cites W2994973788 @default.
• W4284881750 cites W3041626911 @default.
• W4284881750 cites W3104188107 @default.
• W4284881750 cites W3109516676 @default.
• W4284881750 cites W3111255098 @default.
• W4284881750 cites W3118323124 @default.
• W4284881750 cites W3118703752 @default.
• W4284881750 cites W3131279233 @default.
• W4284881750 cites W3137440084 @default.
• W4284881750 cites W3137622503 @default.
• W4284881750 cites W3158666460 @default.
• W4284881750 cites W3158724288 @default.
• W4284881750 cites W3159689317 @default.
• W4284881750 cites W3162857161 @default.
• W4284881750 cites W3166524079 @default.
• W4284881750 cites W3176705561 @default.
• W4284881750 cites W3184211408 @default.
• W4284881750 cites W3190889496 @default.
• W4284881750 cites W4200232721 @default.
• W4284881750 cites W4200582286 @default.
• W4284881750 cites W4206111746 @default.
• W4284881750 cites W4221130777 @default.
• W4284881750 cites W4223436843 @default.
• W4284881750 doi "https://doi.org/10.1007/s40266-022-00959-6" @default.
• W4284881750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35794430" @default.
• W4284881750 hasPublicationYear "2022" @default.
• W4284881750 type Work @default.
• W4284881750 citedByCount "7" @default.
• W4284881750 countsByYear W42848817502022 @default.
• W4284881750 countsByYear W42848817502023 @default.
• W4284881750 crossrefType "journal-article" @default.
• W4284881750 hasAuthorship W4284881750A5003834978 @default.
• W4284881750 hasAuthorship W4284881750A5031844966 @default.
• W4284881750 hasAuthorship W4284881750A5032654392 @default.
• W4284881750 hasAuthorship W4284881750A5033721701 @default.
• W4284881750 hasAuthorship W4284881750A5056707805 @default.
• W4284881750 hasAuthorship W4284881750A5057345227 @default.
• W4284881750 hasAuthorship W4284881750A5058418590 @default.
• W4284881750 hasAuthorship W4284881750A5058618178 @default.
• W4284881750 hasAuthorship W4284881750A5061049836 @default.
• W4284881750 hasAuthorship W4284881750A5065593598 @default.
• W4284881750 hasAuthorship W4284881750A5081399033 @default.
• W4284881750 hasBestOaLocation W42848817501 @default.
• W4284881750 hasConcept C120665830 @default.
• W4284881750 hasConcept C121332964 @default.
• W4284881750 hasConcept C126322002 @default.
• W4284881750 hasConcept C187212893 @default.
• W4284881750 hasConcept C194828623 @default.
• W4284881750 hasConcept C197934379 @default.
• W4284881750 hasConcept C203014093 @default.
• W4284881750 hasConcept C22070199 @default.
• W4284881750 hasConcept C23131810 @default.
• W4284881750 hasConcept C2780868878 @default.
• W4284881750 hasConcept C2908647359 @default.
• W4284881750 hasConcept C61511704 @default.
• W4284881750 hasConcept C71924100 @default.
• W4284881750 hasConcept C8891405 @default.
• W4284881750 hasConcept C99454951 @default.
• W4284881750 hasConceptScore W4284881750C120665830 @default.
• W4284881750 hasConceptScore W4284881750C121332964 @default.
• W4284881750 hasConceptScore W4284881750C126322002 @default.
• W4284881750 hasConceptScore W4284881750C187212893 @default.
• W4284881750 hasConceptScore W4284881750C194828623 @default.
• W4284881750 hasConceptScore W4284881750C197934379 @default.
• W4284881750 hasConceptScore W4284881750C203014093 @default.
• W4284881750 hasConceptScore W4284881750C22070199 @default.
• W4284881750 hasConceptScore W4284881750C23131810 @default.
• W4284881750 hasConceptScore W4284881750C2780868878 @default.
• W4284881750 hasConceptScore W4284881750C2908647359 @default.
• W4284881750 hasConceptScore W4284881750C61511704 @default.
• W4284881750 hasConceptScore W4284881750C71924100 @default.
• W4284881750 hasConceptScore W4284881750C8891405 @default.
• W4284881750 hasConceptScore W4284881750C99454951 @default.
• W4284881750 hasIssue "7" @default.
• W4284881750 hasLocation W42848817501 @default.
• W4284881750 hasLocation W42848817502 @default.
• W4284881750 hasLocation W42848817503 @default.
• W4284881750 hasOpenAccess W4284881750 @default.
• W4284881750 hasPrimaryLocation W42848817501 @default.
• W4284881750 hasRelatedWork W133639369 @default.

• next